FITY (Fifty 1 Labs) Debt-to-Asset : 2.41 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Fifty 1 Labs Debt-to-Asset?

Fifty 1 Labs FITY Debt-to-Asset is 2.41 as of Jun. 2024.

Fifty 1 Labs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.07 Mil. Fifty 1 Labs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was $0.00 Mil. Fifty 1 Labs's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was $0.03 Mil. Fifty 1 Labs's debt to asset for the quarter that ended in Jun. 2024 was 2.41.


Fifty 1 Labs  (OTCPK:FITY) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Fifty 1 Labs Debt-to-Asset Related Terms


Fifty 1 Labs Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Debt-to-Asset Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.84 0.00 4.19 3.58 2.41

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.84 0.00 4.19 3.58 2.41

FITY vs GRPS, KOAN, PTPI: Debt-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fifty 1 Labs's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fifty 1 Labs Debt-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fifty 1 Labs's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fifty 1 Labs's Debt-to-Asset falls into.



Fifty 1 Labs Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fifty 1 Labs's Debt-to-Asset for the fiscal year that ended in Jun. 2024 is calculated as

Fifty 1 Labs's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 2.41 mean?
Fifty 1 Labs (FITY) has a Debt-to-Asset of 2.41 as of Jun. 2024. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Debt-to-Asset too high?
Fifty 1 Labs' current Debt-to-Asset is 2.41.
How does Fifty 1 Labs' Debt-to-Asset compare to GRPS and KOAN?
Fifty 1 Labs' Debt-to-Asset of 2.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Drug Manufacturers company?
A good Debt-to-Asset depends on the Drug Manufacturers industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Fifty 1 Labs and its competitors. Fifty 1 Labs's current Debt-to-Asset is 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Debt-to-Asset of 2.41. The current Debt-to-Asset is 2.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Debt-to-Asset is 2.41 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.